Emily Adland

3.2k citations

31 papers · 800 indexed · h-index 14

Immunology top 10%
Virology top 2%
Epidemiology top 10%
Oncology top 10%
Infectious Diseases top 10%

Co-authors: Philip Goulder Paul Klenerman Philippa C. Matthews Andrew Bell W. Nicholas Haining Claire Shannon‐Lowe Henri‐Jacques Delecluse Maximilian Muenchhoff
Topics: HIV Research and Treatment (22 papers)HIV/AIDS Research and Interventions (15 papers)Immune Cell Function and Interaction (9 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: Proceedings of the National Academy of Sciences PLoS ONE Journal of Virology
Partner nations: United Kingdom South Africa United States

In The Last Decade

Emily Adland

30 papers receiving 795 citations

Peers

Countries citing papers authored by Emily Adland

Since Specialization

Citations

This map shows the geographic impact of Emily Adland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Adland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Adland more than expected).

Fields of papers citing papers by Emily Adland

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Adland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Adland. The network helps show where Emily Adland may publish in the future.

Co-authorship network of co-authors of Emily Adland

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Adland. A scholar is included among the top collaborators of Emily Adland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Adland. Emily Adland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents 2024 ·Frontiers in Immunology ·Oliver Sampson,(unknown),Emily Adland,Anna Csala,Nicholas Lim,(unknown),Lorna C Gilligan,Angela E. Taylor,(unknown),Stephanie Longet,Lucy C. Jones,Eleanor Barnes,John Frater,Paul Klenerman,Susanna Dunachie,(unknown),James Hawley,Wiebke Arlt,Andreas Groll,Philip Goulder	3
2	Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents 2023 ·Frontiers in Immunology ·(unknown),Emily Adland,Anna Csala,Nicholas Lim,Stephanie Longet,Ane Ogbe,Jeremy Ratcliff,Oliver Sampson,Craig Thompson,Lance Turtle,Eleanor Barnes,Susanna Dunachie,Paul Klenerman,Miles W. Carroll,Philip Goulder	6
3	Role of Early Life Cytotoxic T Lymphocyte and Natural Killer Cell Immunity in Paediatric HIV Cure/Remission in the Anti-Retroviral Therapy Era 2022 ·Frontiers in Immunology ·Vinícius Vieira,(unknown),(unknown),Emily Adland,Philip Goulder	5
4	Next-generation point-of-care testing in pediatric human immunodeficiency virus infection facilitates diagnosis and monitoring of treatment 2022 ·Medicine ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Emily Adland,María C. Puertas,Thumbi Ndung’u,Javier Martínez‐Picado,Moherndran Archary,Philip Goulder	0
5	Epigenetic Features of HIV-Induced T-Cell Exhaustion Persist Despite Early Antiretroviral Therapy 2021 ·Frontiers in Immunology ·Geneviève Martin,Debattama R. Sen,Matthew Pace,Nicola Robinson,Jodi Meyerowitz,Emily Adland,John Thornhill,Mathew Jones,Ane Ogbe,Lucia Parolini,Natalia Olejniczak,Panagiota Zacharopoulou,Helen Brown,Christian B. Willberg,Nneka Nwokolo,Julie Fox,Sarah Fidler,W. Nicholas Haining,John Frater	18
6	Increased Regulatory T-Cell Activity and Enhanced T-Cell Homeostatic Signaling in Slow Progressing HIV-infected Children 2019 ·Frontiers in Immunology ·Julia Roider,(unknown),Maximilian Muenchhoff,Emily Adland,Andreas Groll,Thumbi Ndung’u,Henrik N. Kløverpris,Philip Goulder,Alasdair Leslie	10
7	Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children 2019 ·Frontiers in Immunology ·Julia Roider,J. Zachary Porterfield,Paul Ogongo,Maximilian Muenchhoff,Emily Adland,Andreas Groll,Lynn Morris,Penny L. Moore,Thumbi Ndung’u,Henrik N. Kløverpris,Philip Goulder,Alasdair Leslie	4
8	HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic model 2019 ·BMC Medicine ·Anna McNaughton,José Lourenço,(unknown),Emily Adland,Samantha Daniel,(unknown),(unknown),Susan Wareing,Katie Jeffery,M. Azim Ansari,Paul Klenerman,Philip Goulder,Sunetra Gupta,Pieter Jooste,Philippa C. Matthews	13
9	Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort 2018 ·BMC Infectious Diseases ·Emily Adland,Gerald Jesuthasan,Louise Downs,(unknown),(unknown),Anna McNaughton,Jane Collier,Eleanor Barnes,Paul Klenerman,Monique Andersson,Katie Jeffery,Philippa C. Matthews	19
10	High-Frequency, Functional HIV-Specific T-Follicular Helper and Regulatory Cells Are Present Within Germinal Centers in Children but Not Adults 2018 ·Frontiers in Immunology ·Julia Roider,Takashi Maehara,(unknown),Duran Ramsuran,Maximilian Muenchhoff,Emily Adland,Toby P. Aicher,Samuel W. Kazer,Pieter Jooste,Farina Karim,Warren Kuhn,Alex K. Shalek,Thumbi Ndung’u,Lynn Morris,Penny L. Moore,Shiv Pillai,Henrik N. Kløverpris,Philip Goulder,Alasdair Leslie	19
11	Recovery of effective HIV-specific CD4+ T-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia 2018 ·AIDS ·Emily Adland,Luisa Mori,(unknown),Anna Csala,Maximilian Muenchhoff,(unknown),(unknown),Philippa C. Matthews,Gareth Tudor‐Williams,Pieter Jooste,Philip Goulder	5
12	Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations 2017 ·PLoS ONE ·Amna Malik,Emily Adland,(unknown),Henrik N. Kløverpris,(unknown),Julia Roider,Marianne Tang Severinsen,Fabian Chen,Lynn Riddell,Anne Edwards,Søren Buus,Pieter Jooste,Philippa C. Matthews,Philip Goulder	8
13	Paediatric non-progression following grandmother-to-child HIV transmission 2016 ·Retrovirology ·Ming‐Han Tsai,Maximilian Muenchhoff,Emily Adland,Anna Carlqvist,Julia Roider,David K. Cole,Andrew K. Sewell,Jonathan M. Carlson,Thumbi Ndung’u,Philip Goulder	5
14	Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa 2016 ·Journal of Clinical Virology ·Pieter Jooste,(unknown),Emily Adland,Samantha Daniel,(unknown),(unknown),Susan Wareing,Dominique Goedhals,Katie Jeffery,Monique Andersson,Philip Goulder,Philippa C. Matthews	16
15	Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection 2015 ·PLoS ONE ·Masahiko Mori,Emily Adland,P Paioni,(unknown),Luisa Mori,(unknown),Maximilian Muenchhoff,Philippa C. Matthews,Gareth Tudor‐Williams,(unknown),(unknown),Jacob Hurst,Bruce D. Walker,Thumbi Ndung’u,Andrew J. Prendergast,Philip Goulder,Pieter Jooste	18
16	Ongoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy era 2015 ·Frontiers in Microbiology ·Emily Adland,Paul Klenerman,Philip Goulder,Philippa C. Matthews	86
17	Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence 2014 ·Proceedings of the National Academy of Sciences ·Rebecca Payne,Maximilian Muenchhoff,Jaclyn K. Mann,Hannah Roberts,Philippa C. Matthews,Emily Adland,(unknown),Kuan‐Hsiang Gary Huang,Mark A. Brockman,Zabrina L. Brumme,Marc Sinclair,Toshiyuki Miura,John Frater,Max Essex,Roger Shapiro,Bruce D. Walker,Thumbi Ndung’u,Angela R. McLean,Jonathan M. Carlson,Philip Goulder	62
18	Evaluation of the NucliSens EasyQ v2.0 Assay in Comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in Quantification of C-Clade HIV-1 in Plasma 2014 ·PLoS ONE ·Maximilian Muenchhoff,(unknown),(unknown),Emily Adland,Anna Carlqvist,(unknown),Manjeetha Jaggernath,Busisiwe Mlotshwa,(unknown),Thumbi Ndung’u,(unknown)	9
19	HIV Subtype Influences HLA-B07:02-Associated HIV Disease Outcome 2013 ·AIDS Research and Human Retroviruses* ·Henrik N. Kløverpris,Emily Adland,(unknown),Anette Stryhn,Mikkel Harndahl,Philippa C. Matthews,Roger Shapiro,Bruce D. Walker,Thumbi Ndung’u,Christian Brander,Masafumi Takiguchi,Søren Buus,Philip Goulder	16
20	Nef-Specific CD8+ T Cell Responses Contribute to HIV-1 Immune Control 2013 ·PLoS ONE ·Emily Adland,Jonathan M. Carlson,P Paioni,Henrik N. Kløverpris,Roger Shapiro,Anthony Ogwu,Lynn Riddell,Graz Luzzi,Fabian Chen,(unknown),David Heckerman,Anette Stryhn,Anne Edwards,Thumbi Ndung’u,Bruce D. Walker,Søren Buus,Philip Goulder,Philippa C. Matthews	27

About Emily Adland

Emily Adland is a scholar working on Virology, Infectious Diseases and Immunology, having authored 31 papers that have together received 800 indexed citations. Recurring topics across this work include HIV Research and Treatment (22 papers), HIV/AIDS Research and Interventions (15 papers) and Immune Cell Function and Interaction (9 papers). The work is most often cited by research in Virology (269 citations), Immunology (386 citations) and Infectious Diseases (233 citations). Emily Adland has collaborated with scholars based in United Kingdom, South Africa and United States. Frequent co-authors include Philip Goulder, Paul Klenerman, Philippa C. Matthews, Andrew Bell, W. Nicholas Haining, Claire Shannon‐Lowe, Henri‐Jacques Delecluse, Maximilian Muenchhoff, Alan B. Rickinson and Martin Rowe. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact